Ahmet KORKMAZ, M.D., Ph.D.

DOB; November 10, 1970

Position; Prof. of Human Physiology, Head of the Department of Physiology, Gulhane School of Medicine, Ankara, Turkey (from June, 2006 to August, 2016)

Current: Private Practise

E-Mail: fizyocan@gmail.com

Tel: +90 5413768465

He was graduated from Gulhane Military Medical School at 1993. He has got his Ph.D. degree at 1998 from the department of physiology at the same medical school. He was promoted to Associated Professor at 2005 and full professor at 2011. He worked at University of Texas Health Science Center at San Antonio (Dept. of Cellular and Structural Biology) with Prof. Russel J. Reiter for two years.

His research interests are melatonin, medical ozone and hyperbaric oxygen therapy. He has conducted more than 55 national and 4 international projects during the 1999-2015 period. He has looked for the healing mechanism of oxygen based bio-oxidative therapeutics (i.e., medical ozone and hyperbaric oxygen therapies) in a variety of experimental inflammatory and oxidative stress models. His laboratory is also focused on anti-oxidative and anti-nitrosative efficacy of melatonin in several experimental models. Recently, the lab has an emerging interest in the involvement of epigenetic mechanisms in human diseases and the mechanism of mustard toxicity as one of the most challenged issue in chemical warfare agents.

Korkmaz has approximately 140 international and 35 national publications. Korkmaz knows English very well, married and has two sons. He has been professor since 2011 and chair of Departmen of Physiology since 2006. He retired from his position at August 2016.

Dr. Korkmaz has over 200 academic publications and posters; Click for details.

Selected Publications:

1: Tan DX, Hardeland R, Manchester LC, Paredes SD, Korkmaz A, Sainz RM, Mayo JC, Fuentes-Broto L, Reiter RJ. The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc. 2009 Dec 21. [Epub ahead of print] PubMed PMID: 20039865.

2: Korkmaz A, Topal T, Tan DX, Reiter RJ. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord. 2009 Dec;10(4):261-70. PubMed PMID: 19911281.

3: Oztas E, Guven A, Turk E, Uysal B, Akgul EO, Cayci T, Ersoz N, Korkmaz A. 3-aminobenzamide, a poly ADP ribose polymerase inhibitor, attenuates renal ischemia/reperfusion injury. Ren Fail. 2009;31(5):393-9. PubMed PMID: 19839840.

4: Uysal B, Yasar M, Ersoz N, Coskun O, Kilic A, Cayc T, Kurt B, Oter S, Korkmaz A, Guven A. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010 Jan;39(1):9-15. PubMed PMID: 19823101.

5: Ersoz N, Guven A, Cayci T, Uysal B, Turk E, Oztas E, Akgul EO, Korkmaz A, Cetiner S. Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS. Ren Fail. 2009;31(8):704-10. PubMed PMID: 19814638.

6: Guven A, Gundogdu G, Vurucu S, Uysal B, Oztas E, Ozturk H, Korkmaz A. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg. 2009 Sep;44(9):1730-5. PubMed PMID: 19735816.

7: Ersoz N, Ozler M, Altinel O, Sadir S, Ozerhan IH, Uysal B, Topal T, Guven A, Korkmaz A. Melatonin prevents peritoneal adhesions in rats. J Gastroenterol Hepatol. 2009 Nov;24(11):1763-7. Epub 2009 Aug 3. PubMed PMID: 19686418.

8: Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens. 2009 Aug;27 Suppl 6:S17-20. Review. PubMed PMID: 19633446.

9: Ulas U, Korkmaz A, Karadas O, Odabasi Z, Reiter R. Sunrise-related headache: case report. Cephalalgia. 2009 May 15. [Epub ahead of print] PubMed PMID: 19473198.

10: Sizlan A, Guven A, Uysal B, Yanarates O, Atim A, Oztas E, Cosar A, Korkmaz A. Proanthocyanidin protects intestine and remote organs against mesenteric ischemia/reperfusion injury. World J Surg. 2009 Jul;33(7):1384-91. PubMed PMID: 19404709.

11: Kesik V, Guven A, Vurucu S, Tunc T, Uysal B, Gundogdu G, Oztas E, Korkmaz A. Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion. J Surg Res. 2009 Nov;157(1):e97-e105. Epub 2009 Jan 14. PubMed PMID: 19394656.

12: Gulec M, Ogur R, Gul H, Korkmaz A, Bakir B. Investigation of vasoactive ion content of herbs used in hemorrhoid treatment in Turkey. Pak J Pharm Sci. 2009 Apr;22(2):187-92. PubMed PMID: 19339231.

13: Tunc T, Oter S, Güven A, Topal T, Kul M, Korkmaz A, Ongürü O, Sarici U. Protective effect of sulfhydryl-containing antioxidants against ischemia/reperfusion injury of prepubertal rat intestine. J Gastroenterol Hepatol. 2009 Apr;24(4):681-7. Epub 2009 Dec 1. PubMed PMID: 19054265.

14: Paredes SD, Korkmaz A, Manchester LC, Tan DX, Reiter RJ. Phytomelatonin: a review. J Exp Bot. 2009;60(1):57-69. Epub 2008 Nov 25. Review. PubMed PMID: 19033551.

15: Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S, Tan DX. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med. 2009 Jan-Feb;15(1-2):43-50. Epub 2008 Nov 4. Review. PubMed PMID: 19011689; PubMed Central PMCID: PMC2582546.

16: Reiter RJ, Korkmaz A. Clinical aspects of melatonin. Saudi Med J. 2008 Nov;29(11):1537-47. Review. PubMed PMID: 18997997.

17: Reiter RJ, Korkmaz A, Paredes SD, Manchester LC, Tan DX. Melatonin reduces oxidative/nitrosative stress due to drugs, toxins, metals, and herbicides. Neuro Endocrinol Lett. 2008 Oct;29(5):609-13. Review. PubMed PMID: 18987585.

18: Korkmaz A, Kunak ZI, Paredes SD, Yaren H, Tan DX, Reiter RJ. The use of melatonin to combat mustard toxicity. REVIEW. Neuro Endocrinol Lett. 2008 Oct;29(5):614-9. Review. PubMed PMID: 18987575.

19: Ercin CN, Yesilova Z, Korkmaz A, Ozcan A, Oktenli C, Uygun A. The effect of iNOS inhibitors and hyperbaric oxygen treatment in a rat model of experimental colitis. Dig Dis Sci. 2009 Jan;54(1):75-9. Epub 2008 Oct 30. PubMed PMID: 18972208.

20: Guven A, Tunc T, Topal T, Kul M, Korkmaz A, Gundogdu G, Onguru O, Ozturk H. Alpha-lipoic acid and ebselen prevent ischemia/reperfusion injury in the rat intestine. Surg Today. 2008;38(11):1029-35. Epub 2008 Oct 29. PubMed PMID: 18958562.

21: Reiter RJ, Paredes SD, Korkmaz A, Manchester LC, Tan DX. Melatonin in relation to the “strong” and “weak” versions of the free radical theory of aging. Adv Med Sci. 2008;53(2):119-29. Review. PubMed PMID: 18930877.

22: Yanarates O, Guven A, Sizlan A, Uysal B, Akgul O, Atim A, Ozcan A, Korkmaz A, Kurt E. Ameliorative effects of proanthocyanidin on renal ischemia/reperfusion injury. Ren Fail. 2008;30(9):931-8. PubMed PMID: 18925534.

23: Korkmaz A, Topal T, Oter S, Tan DX, Reiter RJ. Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. Mini Rev Med Chem. 2008 Oct;8(11):1144-53. Review. PubMed PMID: 18855729.

24: Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, Reiter RJ. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril. 2009 Jul;92(1):328-43. Epub 2008 Sep 18. Review. PubMed PMID: 18804205.

25: Korkmaz A, Tamura H, Manchester LC, Ogden GB, Tan DX, Reiter RJ. Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line. J Pineal Res. 2009 Jan;46(1):115-6. Epub 2008 Sep 16. PubMed PMID: 18798787.

26: Guven A, Gundogdu G, Sadir S, Topal T, Erdogan E, Korkmaz A, Surer I, Ozturk H. The efficacy of ozone therapy in experimental caustic esophageal burn. J Pediatr Surg. 2008 Sep;43(9):1679-84. PubMed PMID: 18779006.

27: Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC, Paredes SD. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuro Endocrinol Lett. 2008 Aug;29(4):391-8. Review. PubMed PMID: 18766165.

28: Korkmaz A. Epigenetic actions of melatonin. J Pineal Res. 2009 Jan;46(1):117-8. Epub 2008 Aug 13. PubMed PMID: 18705648.

29: Guven A, Uysal B, Akgul O, Cermik H, Gundogdu G, Surer I, Ozturk H, Korkmaz A. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail. 2008;30(7):747-54. PubMed PMID: 18704824.

30: Guven A, Demirbag S, Uysal B, Topal T, Erdogan E, Korkmaz A, Ozturk H. Effect of 3-amino benzamide, a poly(adenosine diphosphate-ribose) polymerase inhibitor, in experimental caustic esophageal burn. J Pediatr Surg. 2008 Aug;43(8):1474-9. PubMed PMID: 18675638.

31: Duz B, Kaplan M, Bilgic S, Korkmaz A, Kahraman S. Does hypothermic treatment provide an advantage after spinal cord injury until surgery? An experimental study. Neurochem Res. 2009 Mar;34(3):407-10. Epub 2008 Jul 17. PubMed PMID: 18633702.

32: Korkmaz A, Sanchez-Barcelo EJ, Tan DX, Reiter RJ. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res Treat. 2009 May;115(1):13-27. Epub 2008 Jul 1. Review. PubMed PMID: 18592373.

33: Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, Manchester LC. Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncog. 2007 Dec;13(4):303-28. Review. PubMed PMID: 18540832.

34: Göcgeldi E, Uysal B, Korkmaz A, Ogur R, Reiter RJ, Kurt B, Oter S, Topal T, Hasde M. Establishing the use of melatonin as an adjuvant therapeutic against paraquat-induced lung toxicity in rats. Exp Biol Med (Maywood). 2008 Sep;233(9):1133-41. Epub 2008 Jun 5. PubMed PMID: 18535163.

35: Korkmaz A. Melatonin as an adjuvant therapy in patients with rheumatoid arthritis. Br J Clin Pharmacol. 2008 Aug;66(2):316-7. Epub 2008 May 27. PubMed PMID: 18507659; PubMed Central PMCID: PMC2492912.

36: Korkmaz A, Kurt B, Yildirim I, Basal S, Topal T, Sadir S, Oter S. Effects of poly(ADP-ribose) polymerase inhibition in bladder damage caused by cyclophosphamide in rats. Exp Biol Med (Maywood). 2008 Mar;233(3):338-43. PubMed PMID: 18296739.

37: Basal S, Irkilata HC, Yildirim I, Sadir S, Korkmaz A, Zor M, Aydur E, Peker AF. Retroperitoneal lymph node mapping with intratesticular injected patent blue dye in rats. Urol Oncol. 2008 May-Jun;26(3):286-90. Epub 2008 Feb 20. PubMed PMID: 18452821.

38: Tekbas OF, Ogur R, Korkmaz A, Kilic A, Reiter RJ. Melatonin as an antibiotic: new insights into the actions of this ubiquitous molecule. J Pineal Res. 2008 Mar;44(2):222-6. PubMed PMID: 18289175.

39: Kurt B, Kurt Y, Karslioğlu Y, Topal T, Erdamar H, Korkmaz A, Türközkan N, Yaman H, Odabaşi Z, Günhan O. Effects of hyperbaric oxygen on energy production and xanthine oxidase levels in striated muscle tissue of healthy rats. J Clin Neurosci. 2008 Apr;15(4):445-50. Epub 2008 Feb 15. PubMed PMID: 18280739.

40: Sonmez A, Yilmaz MI, Korkmaz A, Topal T, Caglar K, Kaya A, Eyileten T, Yenicesu M, Oguz Y, Basal S, Ipcioglu OM, Vural A. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model. Clin Exp Nephrol. 2008 Apr;12(2):110-8. Epub 2008 Jan 5. PubMed PMID: 18175058.

41: Korkmaz A, Reiter RJ. Epigenetic regulation: a new research area for melatonin? J Pineal Res. 2008 Jan;44(1):41-4. Review. PubMed PMID: 18078446.

42: Oter S, Topal T, Sadir S, Ozler M, Uysal B, Ay H, Yaren H, Korkmaz A, Akin A. Oxidative stress levels in rats following exposure to oxygen at 3 atm for 0-120 min. Aviat Space Environ Med. 2007 Dec;78(12):1108-13. PubMed PMID: 18064914.

43: Akay C, Ogur R, Korkmaz A, Gocgeldi E, Yaren H, Gulec M. Could rice be used as an anticaking agent in table salt? Int J Food Sci Nutr. 2007 Sep 18:1-5. [Epub ahead of print] PubMed PMID: 17886084.

44: Ucar M, Korkmaz A, Reiter RJ, Yaren H, Oter S, Kurt B, Topal T. Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett. 2007 Sep 10;173(2):124-31. Epub 2007 Jul 20. PubMed PMID: 17765411.

45: Korkmaz A, Oter S, Sadir S, Topal T, Uysal B, Ozler M, Ay H, Akin A. Exposure time related oxidative action of hyperbaric oxygen in rat brain. Neurochem Res. 2008 Jan;33(1):160-6. Epub 2007 Aug 21. PubMed PMID: 17710543.

46: Ay H, Topal T, Uysal B, Ozler M, Oter S, Korkmaz A, Dündar K. Time-dependent course of hyperbaric oxygen-induced oxidative effects in rat lung and erythrocytes. Clin Exp Pharmacol Physiol. 2007 Aug;34(8):787-91. PubMed PMID: 17600558.

47: Akgül EO, Cakir E, Ozcan O, Yaman H, Kurt YG, Oter S, Korkmaz A, Bilgi C, Erbil MK. Pressure-related increase of asymmetric dimethylarginine caused by hyperbaric oxygen in the rat brain: a possible neuroprotective mechanism. Neurochem Res. 2007 Sep;32(9):1586-91. Epub 2007 Jun 13. PubMed PMID: 17564837.

48: Kahraman S, Düz B, Kayali H, Korkmaz A, Oter S, Aydin A, Sayal A. Effects of methylprednisolone and hyperbaric oxygen on oxidative status after experimental spinal cord injury: a comparative study in rats. Neurochem Res. 2007 Sep;32(9):1547-51. Epub 2007 May 8. PubMed PMID: 17486444.

49: Ay H, Topal T, Ozler M, Uysal B, Korkmaz A, Oter S, Ogur R, Dündar K. Persistence of hyperbaric oxygen-induced oxidative effects after exposure in rat brain cortex tissue. Life Sci. 2007 May 8;80(22):2025-9. Epub 2007 Mar 12. PubMed PMID: 17407783.

50: Korkmaz A, Topal T, Oter S. Pathophysiological aspects of cyclophosphamide and ifosfamide induced hemorrhagic cystitis; implication of reactive oxygen and nitrogen species as well as PARP activation. Cell Biol Toxicol. 2007 Sep;23(5):303-12. Epub 2007 Jan 15. Review. PubMed PMID: 17225077.

51: Mollaoglu H, Topal T, Ozler M, Uysal B, Reiter RJ, Korkmaz A, Oter S. Antioxidant effects of melatonin in rats during chronic exposure to hyperbaric oxygen. J Pineal Res. 2007 Jan;42(1):50-4. PubMed PMID: 17198538.

52: Yaren H, Mollaoglu H, Kurt B, Korkmaz A, Oter S, Topal T, Karayilanoglu T. Lung toxicity of nitrogen mustard may be mediated by nitric oxide and peroxynitrite in rats. Res Vet Sci. 2007 Aug;83(1):116-22. Epub 2006 Dec 29. PubMed PMID: 17196628.

53: Oter S, Korkmaz A. Relevance of hyperbaric oxygen to ozone therapy. Arch Med Res. 2006 Oct;37(7):917-8; author reply 919. PubMed PMID: 16971237.

54: Sadir S, Deveci S, Korkmaz A, Oter S. Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage to bladder tissue in rats. Cell Biochem Funct. 2007 Sep-Oct;25(5):521-6. PubMed PMID: 16850520.

55: Yilmaz MI, Korkmaz A, Kaya A, Sonmez A, Caglar K, Topal T, Eyileten T, Yenicesu M, Acikel C, Oter S, Yaman H, Aktug H, Oguz Y, Vural A, Ikizler TA. Hyperbaric oxygen treatment augments the efficacy of a losartan regime in an experimental nephrotic syndrome model. Nephron Exp Nephrol. 2006;104(1):e15-22. Epub 2006 May 11. PubMed PMID: 16699289.

56: Korkmaz A, Yaren H, Topal T, Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch Toxicol. 2006 Oct;80(10):662-70. Epub 2006 Mar 22. Review. PubMed PMID: 16552503.

57: Dundar K, Topal T, Ay H, Oter S, Korkmaz A. Protective effects of exogenously administered or endogenously produced melatonin on hyperbaric oxygen-induced oxidative stress in the rat brain. Clin Exp Pharmacol Physiol. 2005 Nov;32(11):926-30. PubMed PMID: 16405448.

58: Balkan A, Balkan M, Yasar M, Korkmaz A, Erdem O, Kiliç S, Kutsal O, Bilgic H. Pulmonary protective effects of hyberbaric oxygen and N-acetylcysteine treatment in necrotizing pancreatitis. Physiol Res. 2006;55(1):25-31. Epub 2005 Aug 5. PubMed PMID: 16083313.

59: Oter S, Edremitlioglu M, Korkmaz A, Coskun O, Kilic D, Kisa U, Yaren H, Bilgic H. Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats. Intensive Care Med. 2005 Sep;31(9):1262-8. Epub 2005 Jul 21. PubMed PMID: 16034622.

60: Edremitlioğlu M, Kiliç D, Oter S, Kisa U, Korkmaz A, Coşkun O, Bedir O. The effect of hyperbaric oxygen treatment on the renal functions in septic rats: relation to oxidative damage. Surg Today. 2005;35(8):653-61. PubMed PMID: 16034546.

61: Oter S, Korkmaz A, Topal T, Ozcan O, Sadir S, Ozler M, Ogur R, Bilgic H. Correlation between hyperbaric oxygen exposure pressures and oxidative parameters in rat lung, brain, and erythrocytes. Clin Biochem. 2005 Aug;38(8):706-11. PubMed PMID: 15904909.

62: Korkmaz A, Oter S, Sadir S, Coskun O, Topal T, Ozler M, Bilgic H. Peroxynitrite may be involved in bladder damage caused by cyclophosphamide in rats. J Urol. 2005 May;173(5):1793-6. PubMed PMID: 15821589.

63: Topal T, Oztas Y, Korkmaz A, Sadir S, Oter S, Coskun O, Bilgic H. Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res. 2005 May;38(4):272-7. PubMed PMID: 15813904.

64: Ozcan A, Korkmaz A, Oter S, Coskun O. Contribution of flavonoid antioxidants to the preventive effect of mesna in cyclophosphamide-induced cystitis in rats. Arch Toxicol. 2005 Aug;79(8):461-5. Epub 2005 Mar 31. PubMed PMID: 15800758.

65: Coskun O, Oter S, Korkmaz A, Armutcu F, Kanter M. The oxidative and morphological effects of high concentration chronic toluene exposure on rat sciatic nerves. Neurochem Res. 2005 Jan;30(1):33-8. PubMed PMID: 15756930.

66: Coskun O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and beta-cell damage in rat pancreas. Pharmacol Res. 2005 Feb;51(2):117-23. PubMed PMID: 15629256.

67: Irmak MK, Korkmaz A, Erogul O. Selective brain cooling seems to be a mechanism leading to human craniofacial diversity observed in different geographical regions. Med Hypotheses. 2004;63(6):974-9. PubMed PMID: 15504564.

68: Oztas E, Korkmaz A, Oter S, Topal T. Hyperbaric oxygen treatment time for cyclophosphamide induced cystitis in rats. Undersea Hyperb Med. 2004 Summer;31(2):211-6. PubMed PMID: 15485083.

69: Yildirim I, Korkmaz A, Oter S, Ozcan A, Oztas E. Contribution of antioxidants to preventive effect of mesna in cyclophosphamide-induced hemorrhagic cystitis in rats. Cancer Chemother Pharmacol. 2004 Nov;54(5):469-73. Epub 2004 Jun 30. PubMed PMID: 15232716.

70: Kanter M, Coskun O, Korkmaz A, Oter S. Effects of Nigella sativa on oxidative stress and beta-cell damage in streptozotocin-induced diabetic rats. Anat Rec A Discov Mol Cell Evol Biol. 2004 Jul;279(1):685-91. PubMed PMID: 15224410.

71: Oter S, Korkmaz A, Oztas E, Yildirim I, Topal T, Bilgic H. Inducible nitric oxide synthase inhibition in cyclophosphamide induced hemorrhagic cystitis in rats. Urol Res. 2004 Jun;32(3):185-9. Epub 2004 Jan 31. PubMed PMID: 15205850.

72: Topal T, Oter S, Korkmaz A, Sadir S, Metinyurt G, Korkmazhan ET, Serdar MA, Bilgic H, Reiter RJ. Exogenously administered and endogenously produced melatonin reduce hyperbaric oxygen-induced oxidative stress in rat lung. Life Sci. 2004 Jun 11;75(4):461-7. PubMed PMID: 15147832.

73: Isik AT, Mas MR, Comert B, Yasar M, Korkmaz A, Akay C, Deveci S, Tasci I, Mas N, Ates Y, Kocar IH. The effect of combination therapy of hyperbaric oxygen, meropenem, and selective nitric oxide synthase inhibitor in experimental acute pancreatitis. Pancreas. 2004 Jan;28(1):53-7. PubMed PMID: 14707730.

74: Korkmaz A, Oter S, Deveci S, Ozgurtas T, Topal T, Sadir S, Bilgic H. Involvement of nitric oxide and hyperbaric oxygen in the pathogenesis of cyclophosphamide induced hemorrhagic cystitis in rats. J Urol. 2003 Dec;170(6 Pt 1):2498-502. PubMed PMID: 14634459.

75: Yasar M, Yildiz S, Mas R, Dundar K, Yildirim A, Korkmaz A, Akay C, Kaymakcioglu N, Ozisik T, Sen D. The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. Physiol Res. 2003;52(1):111-6. PubMed PMID: 12625815.

76: Oztas E, Kiliç A, Ozyurt M, Korkmaz A, Başustaoğlu A. Effect of hyperbaric oxygen and penicillin in a murine model of streptococcal myositis. Undersea Hyperb Med. 2001 Fall;28(4):181-6. PubMed PMID: 12153145.

77: Korkmaz A, Oter S, Deveci S, Goksoy C, Bilgic H. Prevention of further cyclophosphamide induced hemorrhagic cystitis by hyperbaric oxygen and mesna in guinea pigs. J Urol. 2001 Sep;166(3):1119-23. PubMed PMID: 11490309.

78: Oğur R, Korkmaz A, Hasde M. Effects of high nitrate intake in rats. J Basic Clin Physiol Pharmacol. 2000;11(1):47-56. PubMed PMID: 10851662.

Scroll Up